ClinicalTrials.gg
RecruitingNCT07233265Updated Nov 24, 2025

Comparison of Single Incision Scrotal vs Standard Two Incision Inguinal Orchidopexy in Children Under 10 Years.

An interventional study of Single scrotal incision orchidopexy and Standard two incision inguinal orchidopexy in Undescended Testis, sponsored by Children Hospital Faisalabad. Recruiting at 1 site in Pakistan. Open to male participants aged 12 Months to 10 Years. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Children Hospital Faisalabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
12 Months to 10 Years
Sex
Male
01

Study summary

This study compares the outcome of single incision scrotal orchidopexy with standard two incision inguinal orchidopexy in children under 10 years of age presented with palpable undesended tesis.The aim is to evaluate operative time,cosmetic outcome and post operative complications.

Read the detailed description

All patients fulfilling the inclusion criteria admitted to paediatric surgery will be included by after taking informed consent from parents. Patients will be randomized in to two groups by lottery method.In group A ,orchidopexy is performed through single scrotal incision .In group B, orchidopexy is performed through standard two incision inguinal approach. This study compares the outcome interm of operative time, cosmetic outcome and post operative complications.

02

Conditions studied

  • Undescended Testis

Browse trials for

Keywords

  • Orchidopexy
  • Scrotal incision
  • Inguinal incision
  • Paediatric surgery
03

In context

Cryptorchidism

40 studies on the registry are indexed under Cryptorchidism; 14 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 26 interventional studies indexed under Cryptorchidism.

Browse Cryptorchidism studies →

Lead sponsor

Children Hospital Faisalabad is the lead sponsor of 5 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Months to 10 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male children with age 1-10 years. Palpable low -lying undesended tesis.

Exclusion criteria

Exclusion Criteria:

  • Impalpable testis Known bleeding disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Single scrotal incision orchidopexy

    Children in this group undergoes single incision scrotal orchidopexy with palpable undesended testis in superficial inguinal canal.

    Procedure: Single scrotal incision orchidopexy

  • Active comparator
    Standard two incision inguinal orchidopexy

    Children in this group undergoes standard two incision inguinal orchidopexy.

    Procedure: Standard two incision inguinal orchidopexy

Interventions

  • ProcedureSingle scrotal incision orchidopexy

    Conventional orchidopexy performed through single scrotal incision

  • ProcedureStandard two incision inguinal orchidopexy

    Conventional orchidopexy performed through separate inguinal and scrotal incision

06

What researchers measure

Primary outcomes

  1. Post operative complications

    Numbers and type of post operative complications (Scrotal hematoma, infection, scrotal edema and testicular atrophy.

    Time frame: With in 24 hours -1month after surgery .

Secondary outcomes

  1. Cosmetic outcome

    Cosmetic appearance of surgical scar assessed by standardized scale. Scale score range (1-10) lower score =better cosmetic outcome. Higher core = worse cosmetic outcome

    Time frame: 2 weeks after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2025; primary completion for May 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 18, 2025
StartEst.
Nov 2025
Primary completionEst.
May 2026
CompletionEst.
Jul 2026
Last update
Nov 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07233265
Lead sponsor
Children Hospital Faisalabad
Responsible party
Ijaz Ul Haq (Principal investigator, department of paediatric surgery, Children Hospital Faisalabad) — Principal investigator
First posted
Nov 18, 2025
Start date
Nov 2025 (estimated)
Primary completion
May 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Nov 24, 2025

Study contacts

Ijaz Ul Haq
Contact
ijazulhaq1995@gmail.com
03305611906

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion